Q4 2019 Earnings Call

Welcome to others fourth quarter 2019 earnings conference call.

Speaking today or Richard Chase open pit, President and Chief Executive Officer.

Brad Cerepak senior Vice President and Chief Financial Officer.

And on your gallium Vice President of corporate development Investor Relations.

After the speaker's remarks, there will be a question and answer period, if you'd like to ask a question. During this time press Star then the number one on your telephone keypad.

He would like to withdraw your question. Please press the pound key on your telephone keypad.

As a reminder, ladies and gentlemen, this conference call is being recorded and your participation implies consent towards recording of this call. If you do not agree to these Harris. Please disconnect at this time.

Thank you I'd now like to hand, the call over to Mr. Andre Kelly. Please go ahead Sir.

Thanks, Nicole good morning, and welcome to doors fourth quarter 2019 earnings call. This call will be available for playback sort of February Twentyth and audio portion of this call will be archived on our website for three months.

No or provide non-GAAP information in the reconciliations between GAAP and adjusted measures included in our Investor supplement and presentation materials, which are available on our website.

Our comments today may contain forward looking statements, we caution everyone to be guided in their analysis of Dover by referring to our Form 10-K or less the factors that could cause our results to differ from those anticipated in any forward looking statement.

We undertake no obligation to publicly update or revise any forward looking statements, except as required by law with that I will turn this call over to rich.

Thanks, Andre good morning, everyone and thanks for joining us on this morning's conference call, let's get started on slide three with key highlights from the fourth quarter and the full year 2019, [laughter] Q4 revenue declined 1% organically due to a tough revenue comp with Q4 2018 that we've been highlighting throughout the year.

Overall 2019 revenue growth was solid up 4% at the high end of our initial annual guidance, that's four or five segments delivered robust growth despite uncertain industrial macroeconomics.

Macro environment.

Some of our end markets an operating geographies.

Bookings in the quarter were approximately flat year over year, posting a solid book to Bill of 1.0 for we are encouraged with the strength of our backlog, which stands at 8% higher than at the beginning of 2019 and is up and four out of our five segments, which will cover later in the presentation.

Despite posting lower revenue our earnings from continuous operations increased with margins in Q4, expanding 140 basis points.

Giving us confidence about our margin aspirations in 2020.

We're forging ahead with our productivity in margin improvement efforts as outlined in our investor presentation in September .

Adjusted Q4 earnings were up 7% and for the full year earnings grew 15% adjusted diluted EPS was $1.54 cents a share for Q4 and 593 for the full year, which represents a 19% increase year over year.

Summing up 2019 was another year of strong performance for Dover, we delivered industry, leading organic growth weights in the top line expanded margins materially improved our cash flow conversion metrics and continue to enhance the quality of the Dover portfolios through organic investments and for bolt on acquisitions.

On the back of a solid order backlog and continued momentum in execution of our margin improvement plans. We are announcing the full year adjusted EPS guidance of $6.20 to $6, a 40 cents a share.

Let's move on to slide four for more detail in the segment performance.

Engineered products segment had a solid finish to a strong year Q4 girls was 3% and full year, 5%.

Born grew in the quarter, a continued strong demand for refuse collection vehicles as well as a continued double digit growth in associated software.

Vehicle service business saw improvement in its European and OEM businesses, and we also Andrew introduced a new Ada Es calibration.

Digital offering and we're excited about its growth prospects are MPG business grew in high single digits as it began shipping against a strong backlog built earlier in the year.

Demand in our industrial winch and industrial automation business has remained subdued as result of cyclical weakness in industrial goods and automotive.

Segment bookings in the fourth quarter was solid at a book to Bill of 1.08, and resulting backlog higher than at the beginning of 2019.

Our Q4 adjusted segment margin expanded 200 basis points on solid volume product mix and productivity measures.

Fueling solutions finished strong and delivered a year of exemplary results full year growth was broad based an 11% on the segment delivered 320 basis point margin improvement with the above ground businesses exiting the year well into the target range of 15% to 17% than we had set for it in 2018.

Demand remains healthy in Q4, yielding 5% growth for the segment. It was particularly strong in North America, where either the compliance demand appears to be gaining momentum bookings in the segment were up 11% organically in Q4, providing a solid base for 2020.

We've completed the integration of bell ones, you're into our vehicle wash platform and the business is on pace to meet or exceed our return on invested capital hurdle.

Imaging and identification declined 2% in the quarter and ended the year with 1% organic growth, marking and coding activity was slow in Asia throughout the year, including in Q4, while other regions performed at just as expected as you know or digital textile printing business can be lumpy on the timing of orders and shipments and impacted by.

Tires and financing availability in the Asian textile producing markets combination as these factors contributed to a slower Q4 in the textile industry activity, but we continue to work with a solid pipe pipeline, a prospective orders false or digital printing work workflow software is showing very good momentum with doubled.

Digit growth backlog for the segment is up 7% year over year.

The segment expanded margin by 200 basis 270 basis points in Q4, and by 260 basis points for the full year. Despite slower top line exemplifying our commitment to improve productivity cost control and pricing discipline.

Lastly, we recently closed the previous previously announced acquisition assist deck, a leading provider of trace ability and brand protection software solutions, primarily to global pharmaceutical manufacturers. This offering fits logically into our met our into our marking and coding portfolio and expands the share of software and service.

Its revenue within Markem imaje to over 15%.

We're excited about the prospects of driving growth by expanding this offering.

Into our high value fast moving consumer goods customer portfolio.

[noise] pumps and processes solution posted an 8% decline as the segment faced a tough comparable in Q4.

As a result of module shipment timing and witnessed a steady slowing during the quarter in the industrial pump market. We're distributors were actively managed at managing down inventory levels.

This in the buyer form a pump in connectors business revenue continued its strong double digit growth and carries a very strong backlog into the new year, we expect the biopharma business to continue its double digit trajectory into 2020.

With respect to DPC, our precision components business activity slowed and what appears to be a temporary low in the natural gas transportation infrastructure build out, but we remain confident about its long term attractiveness.

Despite the upfront.

For mentioned order timing differences maag ended the year, well and carries a strong backlog into 2020.

Summing up all the businesses this segment posted organic growth in 2019.

Yielding a segment growth rate of 4% the segment delivered an outstanding 310 basis point margin improvement for the full year segment is entering 2020 with a backlog of 12% higher year over year, but we expect to get off to a slower start industrial pumps and DPC in the first half.

On a refrigeration and food equipment, it's been and speed on mistakenly tough year for the segment was new food retail store construction continued to lag expectations and negatively impacting our systems and services businesses.

This effect is partially offset by strong sales in the case product line that primarily serve store remodels, which continued to expand at a double digit rate year over year, including on revenue bookings and backlog.

We have not stood still during this period with site consolidations and unified brands and factory automation and case set to contributed positively to earnings in 2020.

Despite a challenging demand environment in 2019, our can forming and heat exchanger businesses returned to growth in Q4.

Bell Vacs backlog is nearly doubled compared to the start of 2019.

Overall the segment interest 2020 on a positive note with with a 19% higher backlog year over year, our operational productivity initiatives remain on track to start delivering results primarily in the second half of 2020.

Ill pass it onto Brad here.

Thanks, Rich good morning, everyone.

Let's start going through the details on slide five.

Rich has provided color on the growth dynamics by segment I will point out.

That on top of the 1% organic revenue decline ethics continue to be a headwind in Q4, reducing topline by 1% were $20 million, we expect FX headwinds to subside in 2020.

Acquisitions, and dispositions, principally ballenger and Fintur contributed a 5 million net increased revenue in the quarter.

Bookings were flat organically and were similarly negative impacted by FX and positively supported by acquisitions.

From a geographic perspective, the U.S., our largest market grew 4% organically for the full year with all businesses, except refrigeration posting solid growth.

Europe was up 6%, we're all five segments posted organic growth in 2019.

All of Asia grew 2% organically for the full year, while China posted 3% growth.

Activity in Asia was mixed across our businesses strong regulatory and new build demand in the fueling and plastics and polymer markets were offset in part by slower demand industrial heat exchangers, and marketing marking and coding.

Latin America was slightly down for the year with a strong first half and a slower second.

Now to the earning earnings bridges on slide six.

Starting at the top.

He neared products.

Adjusted segment, EBITDA improved 9 million, largely driven by volume and mix more than offsetting headwinds from FX fueling solutions growth of 17 million reflects a combination of robust growth continued margin improvement in retail fueling and in part the acquisition of ballenger.

Imaging and identification grew 6 million on strong.

Strong expanded margin despite lower volumes.

The 6 million decline of pumps and process solutions was driven by lower comparable volumes and was partially offset by stronger margins.

Lastly, the decline of 7 million in refrigeration food equipment reflects lower volumes in the quarter.

Going to the bottom of the chart.

Adjusted earnings from continuing operations improved 15 million or 7%, primarily driven by higher segment earnings and lower interest and tax expenses, partially offset by higher corporate costs.

The effective tax rate, excluding discrete tax benefits is approximately 22% for 2019 discrete tax benefits in the quarter were approximately six cents per share.

Rightsizing and other costs, where were $18 million in the quarter or 14 million after tax providing confidence on further reducing costs increasing margins in 2020.

In the quarter, we also refinanced debt due to mature in 2020 and in 2021.

Resulting in a 24 million loss on extinguishment were 18 million after tax.

This loss is treated as an adjustment items EPS in the quarter.

The refinancing results in approximately 13 million lower interest expense on long term debt in 2020.

Now on slide seven.

We finished the year with very strong cash flow free cash flow for the year with 758 million or 140 million over last year, including a 16 million increasing capital expenditures.

The free cash flow increase exceeded growth in earnings, reflecting improved working capital discipline, and resulting in a more than 500 basis point improvement and cash flow conversion as a percent of adjusted earnings.

As a percent of revenue free cash flow was 10.6% for the year or 11.1%. If we exclude cash restructuring expenses, both of which are above the midpoint of our annual guidance of 8% to 12%.

Capital expenditures were 187 million for the year slightly increased compared to the left to last year, but below our original plan.

While our major expansion projects remain on pace with our plan timing of payments related to several large projects will spill over into 2020.

Lastly, let's review slide eight.

The EPS bridge.

We finished the year with a strong 19% increase in earnings per share. This was driven by revenue growth conversion as well as margin improvement activities, resulting in revenue conversion margin well in excess of 100%.

As you can see on this on the chart the strength of the dollar and nine in 2019 resulted in a negative FX impact of approximately 13% of 13 cents of EPS.

Which we do not expect to reoccur in 2020.

All in all we can expect the same dynamic.

Into 2020.

A healthy conversion on revenue growth and operational savings driving year over year EPS accretion.

With that I'll turn it back to rich.

Thanks, Brad let's take a look at the outlooks on slide nine we are entering the year was encouraging backlog in a constructive demand environment across the majority of our markets, allowing us to forecast organic growth of 2% to 3%.

I will cover in detail on the next slide adjusted EPS is forecasted to be $6.20 to $6, a 40 cents a share.

As a result of solid revenue conversion and our previously announced cost savings initiatives, we expect earnings growth to modestly levered in the second half as a real result of seasonality and timing productivity measures.

We expect another strong year of cash flow conversion of 85% to 90% of adjusted net earnings despite higher spending on capital investment.

Engineered products is expected to grow 3% to 5% organically on continued strength in waste handling vehicle service and our aerospace and defense business.

Ruling solution is expected to have a slower 2020 compared to the strong past couple of years as the underground upgrade cycle in China rolls off.

MZ activity in the U.S. has picked up and we expect to gain better visibility in the next couple of quarters about potential upside here.

Imaging, an idea is expected to grow 2% to 3% with the outlook largely dependent on conditions in Asia for both marking and coding and textile printing.

Pumps insulin pumps and process solutions enters the year with a very strong backlog and we expected to grow 3% to 5% geared towards the second half.

And finally in refrigeration food equipment is expected to grow modestly in 2020, we're entering the year with a very strong backlog.

But the trajectory of the past two years calls for caution early in the year overall, our multi industrial portfolio was significant share of aftermarket component and service and software revenue is expected to deliver healthy growth in what continues to be an uncertain macro environment.

[laughter] go to slide 11, Dover strategy is simple, but our aspirations are ambitious we laid out key priorities in 2009 2018.

And our tracking very well delivering against those we plan to advance the same strategy further in 2020.

First you can see from the result of our Rightsizing and operational improvement in our bottom line in our cash flow, we achieved target margin performance in our fueling business in 2020, we'll continue with the prelease previously announced.

50 million dollar cost reduction program as well as our ongoing footprint and productive productivity programs in Dover food retail.

Coupled with healthy healthy growth in conversion. These actions will continue providing a margin accretion tailwind.

Our businesses sustained strong growth, while taking costs out and working on their productivity all under uncertain macro conditions and our top priority in capital deployment is organic reinvestment, we initiated several growth and productivity capital projects and are starting.

Investments.

And our can forming and heat exchanger businesses to capture growing volumes and upgrade competitive capabilities.

Part of our SGN a reduction program was it was reinvested into various growth R&D and digital initiatives and we will continue investing investing and world class digital and operational capabilities in 2020.

Lastly, we committed to disciplined portfolio enhancing M&A over the last 12 months, we have concerns consummated for bolt on high fit accretive propriety transactions in the priority areas of our portfolio. The M&A pipeline remains active going into 2020.

On a final note I'd like to address the inevitable Corona virus questions as best I can at this early stage of developments first and foremost we have been in regular contact with our in country employees and have issued policy guidance using our experience from the sorry, the Sars time period.

We have also put in appropriate travel policies companywide, our production sites had planned to be down from January 24th to Thirtyth for Chinese new year, but we expect to remain down through February 9th in most sites as a result of Cantona enacted safety measures.

In preparation for Chinese new year, Dover, and our supplier network had built inventory to cover this period as normal practice, what we're working closely with our global supply base on potential mitigation strategies actively.

I'd like to thank everybody at Dover for delivering a strong year and the hard work setting us up for a good outlook of 2020.

And that's it and handed over to you Andre for acuity.

Nicole, let's let's open the QNX.

If you would like to ask a question simply press Star then the number one in your telephone keypad. If you would like to withdraw your question. Please press the pound.

We ask that participants limit themselves to one question and one follow up question.

The first question will come from the line of Andrew capital It with Citi.

Hey, good morning, guys.

Hi, Andy.

Rich RFMD, obviously strong backlog now, leaving 2019, I think you said last quarter that good board and Keith bookings could give you more confidence.

For the system side, so the bookings tough to return to growth in beverage can and heat exchangers actually mean that you find the good visibility into organic revenue growth in 2020, well I think on on the can forming for sure.

And on the case side of the refrigeration business, yes.

On the systems and service portion no.

Because that tends to be relatively short cycle in terms of really doesn't carry much of a backlog so.

I think we feel pretty good about the case door backlog that we have going into the year and I think we feel good about belvac and I think that we feel reasonably good.

On swept on the heat exchangers.

Okay. That's helpful and just follow up on dollars any margin you talked about the 15% margin has to exit run rate between 20 to the good bookings in Q4 gives you better shot of hitting that run rate still on track.

You know that margin in the quarter, obviously, you've talked about labor availability and over time as an issue I assume that's what it was again in the quarter and that mitigates as you get the automation project online.

It was it it wasn't as much labor issues that we've had I think those moderated in case door production I think that.

If we had any disappointment in during the quarter was in unified brands. We had the orders we could have shipped but we are in the middle of doing a plant consolidation and our performance spend a little bit lumpy. There so I think that.

I think that we've got some of our labor issues behind us.

In case door, leading into automation and I think that from what I've seen at least at the beginning of this year. The unified brands is began their shipment rates have gone back up so I think we're okay. There also.

Do you think you could hit mid teens and you go out we ended the year.

Right, Yes, I mean, I think that our expectation is the exit at our target margin Andy.

Excellent thanks Corey.

Thanks.

The next question will come from the line of Jeff Sprague with vertical research.

Yes, thanks, good morning.

Morning, just.

Morning, just on the automation project itself, which can you just update us.

Just kind of what happens here the next quarter or two so you're starting to run beta and cut over.

Mike, whereas kind of the stress point on the organization to get this right.

That organization has been under a lot of stress, but in this particular case.

We will be building inventory for the transition through the first six months the year. So I think it's going to be a little bit challenge from a working capital point of view.

We will be getting the beta units off.

With the next month or so and then our target is to the cut over of manufacturing on a single product line in approximately June .

But as we mentioned before we're not this automation Prague project is not running inside the existing assembly operations of case store. So we don't expect to have.

Any downtime associated with the startup it's just the costs associated with the startup, including the working capital build.

And just thinking about the profitability in your backlog right I mean, a lot of that will hinge on the execution in the factory but.

As you tried to trying to streamline the SKU Pal and alike.

Do you feel like you have.

You know kind of real visibility on the backlog profitability at slope than how how much of a part of that to the kind of the exit rate that you're talking about for the year.

I think that we've got better visibility that we have it had.

I guess previously.

So part and parcel to reaching our exit margins is some confidence in terms of of our but what we have in the backlog and the margin that we should generate.

Off of it so it's not predicated completely on cost reduction as a result of labor content in assembly.

Okay, Great I'll leave it there thank you.

The next question is from the line of John inch with Gordon Haskett.

Thank you good morning, everybody good morning, Brad Good morning, Andre So.

Zero to 2% RFP guide, which weapon beldock coming back and rich you called out case door strength I mean does that obviously implies that the rest of that business is down.

Is that business down getting better or are you just assuming it down the way, it's always been down there or how should we think about it.

I think that that we'd well, we'd let we need to parse some of the pieces, but if you go back and listen when you read the transcript I think that we are.

We're being cautious.

With that particular segment because the fact of the matter is it needs to demonstrate a couple of quarters of getting its feet under it but.

I think that the part that we are.

I'm going to wait and see mode is on the systems and service portion of the portfolio. We're confident that case door should be up year over year.

As I mentioned, we feel good about swept when we feel good about belvac.

[music].

And then we'll see.

The 5.4% margin this quarter I mean, if you hadn't been running these parallel systems in the automation project, where there any way to get a sense of where that margin might have been if you hadn't been doing this stuff.

I guess, there could be but I don't have an in front of me right, but there are.

There's a bunch of cost that we did take during the quarter that because of both the transitions largely in you'd be this time around.

That we could normalize, but I don't want to give out and that's like as well. If this didnt count. This is what our margin would be I. Just can give you an idea of what we expected to be in 2020 without recasting the quarter, we're just going up to take our lumps and we're not happy with the performance. We think we've got some good line of sight.

On the non refrigeration portion of the portfolio when it's up to us to deliver on the refrigeration pace.

That's fair just lastly, rich I remember a conversation we had where you were pretty adamant you were going we're not going to chase industrial quote unquote software deals and pay the big multiple some of these other companies have paid and now you've done it would appear to be a couple of pretty pretty nice fit bolt on software deals I'm wondering how you're thinking.

Thinking about this if you've been able to find kind of a niche of some higher technology higher value add without overpaying as you look at the portfolio and look to ramp up M&A going forward I think that software by its nature evaluations are higher than kind of core industrial so it's not as but I think the my comment was more than.

We're not going to chase software.

Damn the torpedoes right, we're an independent of Arpus independent of our business. So the software deals that we've done.

Our comp are highly complimentary both to am I.

And to SG.

I think do we paid a fair price, but the fact of the matter as that software and commands a higher multiples.

Got it thanks very much appreciate it Parker.

The next question is from the line of Julian Mitchell with Barclays.

Thanks, Good morning.

Maybe just following up on how you're thinking about the seasonality through the year I think you'd mentioned.

In pumps in process in refrigeration and food in particular.

Quite a backend loaded year. So just wanted to check if you think Dover as a whole can be in that 2% to 3% organic sales growth range through each quarter.

And also whether that net 50 million of cost save we should just spread out evenly through the year.

Let's take the second question first yes.

On the 50 million to spread it evenly through the year I think it's the safest bet, it's not incredibly material to the to the overall earnings but I get it it's material to the year over year projected change.

I look I think that.

I would I don't think it's going to be disproportionate in terms of the revenue growth, but clearly.

We need to see where we are on pumps on industrial pumps. In Q1, we know that maag and DPC are going to be levered, because those are bigger projects.

So there's some caution in those two particular businesses.

The upside is CMV right. So if you if we take it when we go back and take a look at Q4.

I think we were a little bit disappointed in the demand I think we had signaled that that industrial pumps was slowing at the end of Q3, it slows slowed quite a bit as you can see in Q4.

So that was a kind of a disappointment for versus what our forecast where but we over delivered to such an extent any MV kind of net neutralized where we were.

On on DFE.

I think that the earnings are backend loaded not necessarily the revenue because we've got some pretty healthy backlogs on refrigeration.

Thank you very much and just my follow up on capital deployment.

In 2019.

If I looked at the cash you spin on buyback in M&A and Capex each of those three items, where in that sort of 150 ish to 200 million dollar range rounding wise just wondered when you're thinking about 2020 can see the the share count assumption you peg can see the capex.

Range you have provided.

But would you be surprised if that spread is broadly similar in 2020 as it was in 19.

I think that.

The Capex is our best estimate at this time.

I think that we would prefer.

The weighting towards inorganic investment to go up and capital returned to go down, but if we're not spending it on one side than it is going to come back on the other side.

Great. Thank you welcome.

Next we have inter open with bank of America.

Hi, This is David Ridley Lane on for Andrew.

What gives you.

Confidence around the demand improving.

Thompson process solution as you go through 2020.

I heard your commentary that.

Yes.

We could be softer here in the first half.

Our biopharma business, we expect to again grow in double digits.

[music].

I think that are caution is around industrial pumps.

We have.

Good backlogs on a project basis in Maag.

So we feel good about that and then DPC were betting on a little bit of return to growth largely in the second half. So I think we've got its glass half full scenario. We've got some backlogs in our project related businesses that to the extent everything remains firm will deliver on those.

We're going to be a little bit cautious on an industrial pump demand until we see and interact with our dealers a little bit about where they stand at the stocking levels and the like.

So.

I think that that gives us some confidence that the only risks that we're taking in terms of the growth.

Is largely on the industrial pumps side.

Got it and did the tone shift with customers around the upgrades is there a greater sense of urgency and any updated thoughts on on MP demand.

After 2020.

Sure.

I guess, if we look at Q4.

You can make an argument that the phasing of the demand could be pulled into 2020, but we don't have enough data.

The allows us to say that lets move that number up in terms of how would extrapolates into revenue, but clearly what's happening is as you can read the newspaper everyday you are getting now the first.

Instances of credit card fraud.

At retail operations and once you have that that kind of jumped a lot of people into action. So I think thats the phenomenon that we see.

Understood. Thank you very much you're welcome.

Your next question comes from the line of Nigel call with Wolfe Research.

Thanks, Good morning.

You bet you just wanted to kind of.

Kind of follow up on the on the on pump that look up the industrial pumps as the are concerned how much how much backlog do you have kind of underwritten already between 20 and not revenue growth outlook, you've you've got and how that compared to sort of a normal sort of backlog builds into into the fiscal year.

While the absolute value of the new segment in terms of backlog is up.

But that is weighted towards DPC, and mug, which tend to be project driven so we've got some line of sight on that the industrial partially portion of the business outside of Biopharma.

Is is flat and that's also the where the vast majority of the revenue stream goes through distribution, so as I mentioned earlier.

Earlier.

We saw an amount of inventory management.

Going into Q4.

We need to see where we stand and we need to get a corner under our belt to kind of so I think we're cautious about industrial on the industrial pump demand, but I think we think we feel good about biopharma and we feel good about mug.

Just based on the backlog.

Okay. That's helpful. I mean, if you'd be able to help with the if you go any color on in terms of where distributor and channel inventories are right now, but I did want to touch on Capex.

You know, it's running at a $200 million, which is about chips in the sales typically you've been running a 2% nothing both your mulkins appears.

Not tips in zone I know you Yeah, I know you're investing you just mentioned you've got a preference for internal investment because I'm just curious how long do you think capex will remain at these levels. When do you see it does come back.

I think we're still spending on the brand new side for our Biopharma business that there's going to roll off so as Brad mentioned before we under spent our guidance on Capex one of the reasons that we did was.

I think we underestimated how cold it is in Minneapolis to get that building stood up sells part of the spending has rolled into.

Into 2020 that to me as a onetime or we don't have anything like that so we really have two or three really big projects running through our capex spending now I think we highlighted mid 2018.

Using round figures in aggregate that is close to between 90 and 100 million of Capex spend.

We probably spent 60, 50% to 60% in 2019, we're going to roll forward to 40.

Unless we come up with another project that says we're going to build a brand new building based on growth.

I would expect that amount of capex to come down as a percentage of revenue.

Thank you.

Next we have a question from the line of Josh Pokrzywinski with key with Morgan Stanley .

Hi, Good morning, guys, Hey, Josh.

Rich just on imaging and I'd I think the 2% to 3% seems like it would be similar to what would be in a normal year. I know you may be some some persistent weakness in the fourth quarter that doesn't give you all the optimism in the world, but youre coming off some fairly easy comps.

Yeah, the business doesn't seem like it takes a long time to build momentum once it's generated.

At what point in time.

Could we start to see more more momentum there are we kind of walked into a week one Q just based on your visibility and from there it becomes more of a macro call can you just kind of walk us through the phasing of what a better scenario would look like timing wise.

It's very Asia dependent and forget the recent news around Asia Asia slowed progressing really.

And that particular sector I'm talking about them.

Printing and I'd portion of the business.

Throughout 2019, so I think we were relatively cautious about.

Expectation, there quite frankly going into 20.

We didn't make some deliveries that we thought we were going to make in digital printing in Q4 because of financing letters of credit in the like.

So part and parcel to that growth rate for 20 is somewhat levered onto the textile printing business because we believe that the that the orders are there we just need to.

Sort out some of the financing on it so it's hard to say I mean, I think that's a question that we can probably answer at the end of Q1 once we see what's actually happening in Asia on the on the printing and I decided to say, whether we're going to have an inflection point.

Having said that we've just invested in accomplishment complementary.

Revenue stream for Markem Imaje so.

Let's see what we can do with that going forward.

Got it and then just taking a step back obviously a lot of focused the last couple of years on productivity in.

2020, certainly has a lot more with some of the investments, you're making capex and otherwise.

His 2020 year, where you can start to shift your gaze toward the portfolio.

Whether it's on the M&A side or are examining maybe noncore pieces of the business or is this still going to be kind of like an ice down productivity focus year in its entirety.

I'm sure the management team is not going to like when I say this but the productivity issued never goes away right. So what we are what we're going to grind out in 20 is our expectation to grind down and 21 and going forward and that's why we're.

Investing quite a bit in our digital efforts and our back office efforts in a variety of other things. So we're taking the PNM costs of end of investing in those areas.

With the expectation that we can grind out the productivity in the following years. So that really doesn't go away. We actually have spent a considerable amount of time on our portfolio.

It hasn't translated into a lot of inorganic activity, but it's not from a lack of trial.

Got it.

Appreciate it thanks.

The next question is from the line of Joe Ritchie with Goldman Sachs.

Thanks, Good morning, everyone organic morning.

Just in your in your fueling solutions organic growth guide how much of a headwind is baked in for China underground.

Subsiding here in 2020.

[noise] in percentage terms I don't recall I think it was 50 million more or less in terms of absolute revenue.

Okay, all right cool and.

And then a and then specifically on capital deployment I may Miss This earlier I know you talked a little bit about M&A.

But how are you guys thinking about the toggle on buyback and what should we kind of baked in.

Or what is baked into your expectations for 2020.

It's kind of we reset the clock Joe back to 2018, we said we weren't going to sit on a cash file our preference is to deployed inorganically.

Obviously, we.

Did purchase what's the total hundred 40 million in 140 343 million of equity back. This year, just because we haven't been deploying it inorganically my preference.

In 20 would be the proportionality of inorganic investment to rise.

But if we can't deploy it efficiently with high returns then can expect to say.

Makes sense thanks, guys.

Next we have a question from the line of the Andrei with RBC.

Hi, Thanks. Good morning. This is Andrew Carol on for Dean can you comment on price cost environment, you're seeing now and then what's being assumed for 2020 and if you're still see any impacts from Paris. Thanks.

I think there were neutral on year over year input costs right now I think that we've got we picked up I think the year over year benefit on inputs in the second half of 2019, so our expectation is.

Relatively neutral and we think at pricing should be in excess of inflationary inputs, which includes which includes labor is really our goal.

Got it thanks, and then just a quick follow up.

Let me now you have the 50 million take out cost take out target for 2020, just if the macro slowdown where there is there any potential engage in further restructuring and size, maybe what additional savings that you can reaffirm that thank you.

Yeah, I think the but we're taking out of the 50 has nothing to do with the demand cycle. So that 50 is just core reduction of costs.

If the demand cycle was to turned against US clearly we would take action on our cost base.

Okay. Thank you yes.

And last question comes from line, Steve Tusa with JP Morgan.

Hey, guys. Thanks for fitting me in here at the end [laughter].

Dave.

[laughter] alright.

Hi, when you guys think about kind of the dynamics around envied just.

Can you just remind us kind of how that plays out beyond 20, and you know what how you see that kind of you know trending in 21 and 22, what we have to keep mind on that front.

Yes, we had.

Our our previous estimates was the peak amount would be 2020.

And they would have reduced aggressively in 21, and 22 more or less about 30% to year.

Based on the exit rate that we saw in the fourth quarter, there's an argument to be made.

That it may be higher in 2020, and 21 because of adoption rates, but.

We only have one quarter of data point.

To model it but.

I think that as I mentioned, if you heard during the.

During the presentation.

We know that we've got a headwind in China demand on the underground side, we may have a tailwind on M&A, but we'd like to get a corner under our belt to see how thats progressing.

Okay.

Great and then just on refrigeration.

And what stage do you kind of reevaluate the strategy with tighten up trying to operate that business better is that do you feel better about that today or or you know a little more cautious about it given the.

The sluggish stubbornly kind of sluggish performance.

Look I mean, we're committed to two intervening on the cost base and this is the year when it takes place to sell.

We're going to we're going to run it for the year I think that they were were intervening.

Is where our backlog has the strongest sell that gives us some pause for.

First success there are tertiary pieces of the refrigeration side that we're taking a look at that not actively not kind of the production of case door.

But on the case door side I think that this is the year.

That we got to we got to deliver quite right.

Got it okay. Thanks, a lot thanks.

Thank you that concludes our question and answer period I will now turn the call back over to Mr. Gallagher for closing remarks.

Thanks. This concludes our conference call. Thank you for interest in Dover, and we look forward to speaking to you in next quarter.

Thank you everyone.

Thank you you may now disconnect your lines at this time and have a wonderful day.

[music].

Q4 2019 Earnings Call

Demo

Dover

Earnings

Q4 2019 Earnings Call

DOV

Thursday, January 30th, 2020 at 3:00 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →